These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 26424394)

  • 1. New Pharmacological Approaches to the Prevention of Myocardial Ischemia- Reperfusion Injury.
    Chin KY; Qin C; May L; Ritchie RH; Woodman OL
    Curr Drug Targets; 2017; 18(15):1689-1711. PubMed ID: 26424394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flavonols and Flavones - Protecting Against Myocardial Ischemia/Reperfusion Injury by Targeting Protein Kinases.
    Woodman OL; Chin KY; Thomas CJ; Ng DCH; May CN
    Curr Med Chem; 2018; 25(34):4402-4415. PubMed ID: 29589528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardioprotection of pharmacological postconditioning on myocardial ischemia/reperfusion injury.
    Wu Y; Liu H; Wang X
    Life Sci; 2021 Jan; 264():118628. PubMed ID: 33131670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effects of ranolazine and propranolol, alone or combined, on the structural and functional alterations of cardiomyocyte mitochondria in a pig model of ischemia/reperfusion.
    Dehina L; Descotes J; Chevalier P; Bui-Xuan B; Romestaing C; Dizerens N; Mamou Z; Timour Q
    Fundam Clin Pharmacol; 2014 Jun; 28(3):257-67. PubMed ID: 23607936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoparticle-Mediated Targeting of Cyclosporine A Enhances Cardioprotection Against Ischemia-Reperfusion Injury Through Inhibition of Mitochondrial Permeability Transition Pore Opening.
    Ikeda G; Matoba T; Nakano Y; Nagaoka K; Ishikita A; Nakano K; Funamoto D; Sunagawa K; Egashira K
    Sci Rep; 2016 Feb; 6():20467. PubMed ID: 26861678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Myocardial Ischemia/Reperfusion Injury by Ischemic and Pharmacological Postconditioning.
    Heusch G
    Compr Physiol; 2015 Jul; 5(3):1123-45. PubMed ID: 26140711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection by Cyclosporin A of ischemia/reperfusion-induced damage in isolated rat hearts.
    Griffiths EJ; Halestrap AP
    J Mol Cell Cardiol; 1993 Dec; 25(12):1461-9. PubMed ID: 7512654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial permeability transition in cardiac ischemia-reperfusion: whether cyclophilin D is a viable target for cardioprotection?
    Javadov S; Jang S; Parodi-Rullán R; Khuchua Z; Kuznetsov AV
    Cell Mol Life Sci; 2017 Aug; 74(15):2795-2813. PubMed ID: 28378042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effects of M40403, a selective superoxide dismutase mimetic, in myocardial ischaemia and reperfusion injury in vivo.
    Masini E; Cuzzocrea S; Mazzon E; Marzocca C; Mannaioni PF; Salvemini D
    Br J Pharmacol; 2002 Jul; 136(6):905-17. PubMed ID: 12110615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ischemic heart disease and antioxidants: mechanistic aspects of oxidative injury and its prevention.
    Janero DR
    Crit Rev Food Sci Nutr; 1995 Jan; 35(1-2):65-81. PubMed ID: 7748481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cardioprotectant 3',4'-dihydroxyflavonol inhibits opening of the mitochondrial permeability transition pore after myocardial ischemia and reperfusion in rats.
    Woodman OL; Long R; Pons S; Eychenne N; Berdeaux A; Morin D
    Pharmacol Res; 2014 Mar; 81():26-33. PubMed ID: 24521796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The novel H
    Testai L; Marino A; Piano I; Brancaleone V; Tomita K; Di Cesare Mannelli L; Martelli A; Citi V; Breschi MC; Levi R; Gargini C; Bucci M; Cirino G; Ghelardini C; Calderone V
    Pharmacol Res; 2016 Nov; 113(Pt A):290-299. PubMed ID: 27616550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
    Ferdinandy P; Schulz R; Baxter GF
    Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial permeability transition in the diabetic heart: contributions of thiol redox state and mitochondrial calcium to augmented reperfusion injury.
    Sloan RC; Moukdar F; Frasier CR; Patel HD; Bostian PA; Lust RM; Brown DA
    J Mol Cell Cardiol; 2012 May; 52(5):1009-18. PubMed ID: 22406429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The production of hydrogen sulfide limits myocardial ischemia and reperfusion injury and contributes to the cardioprotective effects of preconditioning with endotoxin, but not ischemia in the rat.
    Sivarajah A; McDonald MC; Thiemermann C
    Shock; 2006 Aug; 26(2):154-61. PubMed ID: 16878023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orientin-induced cardioprotection against reperfusion is associated with attenuation of mitochondrial permeability transition.
    Lu N; Sun Y; Zheng X
    Planta Med; 2011 Jul; 77(10):984-91. PubMed ID: 21283956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antioxidants and myocardial ischemia: reperfusion injuries.
    Chen JK; Chow SE
    Chang Gung Med J; 2005 Jun; 28(6):369-77. PubMed ID: 16124152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effects of cyclo(L-Leu-L-Tyr) against postischemic myocardial dysfunction in guinea-pig hearts.
    Mitsui-Saitoh K; Furukawa T; Akutagawa T; Hasada K; Mizutani H; Sugimoto Y; Yamada J; Niwa M; Hotta Y; Takaya Y
    Biol Pharm Bull; 2011; 34(3):335-42. PubMed ID: 21372381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporin A and cardioprotection: from investigative tool to therapeutic agent.
    Hausenloy DJ; Boston-Griffiths EA; Yellon DM
    Br J Pharmacol; 2012 Mar; 165(5):1235-45. PubMed ID: 21955136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-associated differences in the inhibition of mitochondrial permeability transition pore opening by cyclosporine A.
    Liu L; Zhu J; Brink PR; Glass PS; Rebecchi MJ
    Acta Anaesthesiol Scand; 2011 May; 55(5):622-30. PubMed ID: 21827445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.